Page 58 - Sohini Das

Price war begins for Novartis cardiac drug as JB Pharma cuts rate by 50%

Novartis' blockbuster drug is set to lose patent in Jan; JB Pharma, one of the four marketers in India of generi versions, has slashed the price of its brand Azmarda to Rs 39.6 a tablet

Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday

He was earlier the firm's deputy CEO; Outgoing MD Arun Chandavarkar to remain on co Board

Lessons from Covid: Pharma firms turn attention to adult vaccination

Vaccine companies have warmed up to the idea of adult vaccines for other diseases such as pneumonia, flu and shingles as well

After the anti-diabetic market, India's cardiac market in for a shake-up

Sun Pharma has the largest share in the Indian cardiac market, followed by Torrent Pharma, Lupin and USV

Pharma, consumer durables sectors likely to feel China curb heat

Industry players say lockdown could have an impact on the supply of components used in consumer durables

Flu season starts, but demand for cough-cold meds remains weak

Impact in US among the worst in the past 10 years

With the flu season here, should you ask for an influenza vaccine?

Demand for flu vaccine weak in India; US facing worst season in a decade

State govts on overdrive to vaccinate as measles outbreaks spread

Outbreaks have been reported in several states including Maharashtra, Kerala, Bihar, Jharkhand, Gujarat and Haryana

Gland Pharma to acquire French firm Cenexi Group for Rs 1,000 crore

Will fund transaction from internal accruals

Bharat Bio looks for partners to manufacture, distribute iNCOVACC globally

Its local production ramp-up remains unhurried as demand for boosters reduces

Bharat Biotech gets nasal vaccine nod for use as mix-match booster

iNCOVACC first intranasal Covid shot to receive approval for primary 2-dose schedule, heterologous booster us

China-Plus-One strategy: Indian API firms start to reap benefits

Rising Chinese labour costs, geopolitics, pandemic-stricken uncertainties have forced global players to derisk

As China intensifies Covid restrictions, India begins to relax curbs

Data shows that spike in one country has not coincided with a rise in the other

Zuventus first in world to launch aviptadil for ARDS commercially

Discovered in 1970, the drug was tested on severe Covid-19 patients on DCGI's direction

As China intensifies Covid-19 lockdowns, India gradually opens up

Data shows that spike in one country has not coincided with a rise the other

Orchid Pharma antibiotic product for treating UTI coming to India: MD

Company says it's returning to profit after takeover by Dhanuka Laboratories under insolvency resolution

World in turmoil, domestic pharma firms target India for healthy growth

Share of India revenue in home-grown firms' consolidated turnover rising over the years

Removing vaccination mandate for incoming tourists correct move: Experts

With over 90% of population being vaccinated, it is okay at a policy level to relax the mandatory vaccination norm for entering India, they say

Top 300 drug brands to now have QR codes on label for ensuring authenticity

Govt finalises the draft notification issued in June

Suven starts Phase 3 trial for first home-grown Alzheimer's drug

Clinical trial randomisation is the process of assigning patients by chance to groups that receive different treatments